This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Synta Pharmaceuticals Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jaime Acquaviva: Innovator in Pharmaceutical Combinations
Introduction
Jaime Acquaviva is a notable inventor based in Ashland, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of combination therapies. Her work focuses on innovative solutions for treating proliferative disorders.
Latest Patents
Jaime Acquaviva holds 1 patent for her invention titled "Combination therapy of HSP90 inhibitors with BRAF inhibitors." This patent describes a pharmaceutical combination that includes a BRAF inhibitor and an Hsp90 inhibitor, along with a method for treating a proliferative disorder in a subject in need thereof. The detailed formulae and variables are defined within the patent documentation.
Career Highlights
Jaime is currently employed at Synta Pharmaceuticals Corporation, where she continues to advance her research and development efforts. Her work at Synta has positioned her as a key player in the pharmaceutical industry, contributing to innovative treatment options.
Collaborations
Jaime collaborates with various professionals in her field, including her coworker, David Proia. Their combined expertise enhances the research and development processes at Synta Pharmaceuticals Corporation.
Conclusion
Jaime Acquaviva's contributions to pharmaceutical innovations, particularly in combination therapies, highlight her role as a leading inventor in the industry. Her work continues to pave the way for new treatment options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile